Heart in Jeopardy: Innovations in Hypertrophic Cardiomyopathy
Despite the relatively high prevalence of hypertrophic cardiomyopathy (HCM), reported to be as high as 1 in 200 individuals, most individuals are undiagnosed and untreated. The pathophysiology of HCM is complex and consists of multiple interrelated abnormalities. In order to move the needle from an often-fatal condition to a treatable chronic condition, clinicians must be able to identify patients, understand the challenges of diagnosis, and implement new and emerging treatment options for their patients.
The categories are...Join us for a unique and interactive educational symposium on HCM. In this jeopardy-style symposium, align yourself with one of our expert panelists and let your knowledge of HCM guide your team to victory!
Faculty:
Sara Saberi, MD, MS
Ahmad Masri, MD, MS
Florian Rader MD, MSc
Hosted by Medscape through an independent educational grant provided by Cytokinetics